Literature DB >> 30595674

Allowing for informative missingness in aggregate data meta-analysis with continuous or binary outcomes: Extensions to metamiss.

Anna Chaimani1, Dimitris Mavridis2, Julian P T Higgins3, Georgia Salanti4, Ian R White5.   

Abstract

Missing outcome data can invalidate the results of randomized trials and their meta-analysis. However, addressing missing data is often a challenging issue because it requires untestable assumptions. The impact of missing outcome data on the meta-analysis summary effect can be explored by assuming a relationship between the outcome in the observed and the missing participants via an informative missingness parameter. The informative missingness parameters cannot be estimated from the observed data, but they can be specified, with associated uncertainty, using evidence external to the meta-analysis, such as expert opinion. The use of informative missingness parameters in pairwise meta-analysis of aggregate data with binary outcomes has been previously implemented in Stata by the metamiss command. In this article, we present the new command metamiss2, which is an extension of metamiss for binary or continuous data in pairwise or network meta-analysis. The command can be used to explore the robustness of results to different assumptions about the missing data via sensitivity analysis.

Entities:  

Keywords:  informative missingness; meta-analysis; metamiss2; mixed treatment comparison; sensitivity analysis; st0540

Year:  2018        PMID: 30595674      PMCID: PMC6309174     

Source DB:  PubMed          Journal:  Stata J        ISSN: 1536-867X            Impact factor:   2.637


  9 in total

1.  Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis.

Authors:  Ian R White; James Thomas
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

Review 2.  Evaluation of networks of randomized trials.

Authors:  Georgia Salanti; Julian P T Higgins; A E Ades; John P A Ioannidis
Journal:  Stat Methods Med Res       Date:  2007-10-09       Impact factor: 3.021

3.  Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis.

Authors:  Loukia M Spineli; Julian Pt Higgins; Andrea Cipriani; Stefan Leucht; Georgia Salanti
Journal:  Clin Trials       Date:  2013-01-15       Impact factor: 2.486

4.  Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods.

Authors:  Ian R White; Julian P T Higgins; Angela M Wood
Journal:  Stat Med       Date:  2008-02-28       Impact factor: 2.373

5.  Allowing for uncertainty due to missing data in meta-analysis--part 2: hierarchical models.

Authors:  Ian R White; Nicky J Welton; Angela M Wood; A E Ades; Julian P T Higgins
Journal:  Stat Med       Date:  2008-02-28       Impact factor: 2.373

6.  Allowing for missing outcome data and incomplete uptake of randomised interventions, with application to an Internet-based alcohol trial.

Authors:  Ian R White; Eleftheria Kalaitzaki; Simon G Thompson
Journal:  Stat Med       Date:  2011-09-21       Impact factor: 2.373

7.  Imputation methods for missing outcome data in meta-analysis of clinical trials.

Authors:  Julian P T Higgins; Ian R White; Angela M Wood
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

8.  Evaluating the quality of evidence from a network meta-analysis.

Authors:  Georgia Salanti; Cinzia Del Giovane; Anna Chaimani; Deborah M Caldwell; Julian P T Higgins
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

9.  Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis.

Authors:  Dimitris Mavridis; Ian R White; Julian P T Higgins; Andrea Cipriani; Georgia Salanti
Journal:  Stat Med       Date:  2014-11-13       Impact factor: 2.373

  9 in total
  7 in total

Review 1.  Interleukin-1 blocking agents for treating COVID-19.

Authors:  Mauricia Davidson; Sonia Menon; Anna Chaimani; Theodoros Evrenoglou; Lina Ghosn; Carolina Graña; Nicholas Henschke; Elise Cogo; Gemma Villanueva; Gabriel Ferrand; Carolina Riveros; Hillary Bonnet; Philipp Kapp; Conor Moran; Declan Devane; Joerg J Meerpohl; Gabriel Rada; Asbjørn Hróbjartsson; Giacomo Grasselli; David Tovey; Philippe Ravaud; Isabelle Boutron
Journal:  Cochrane Database Syst Rev       Date:  2022-01-26

2.  Interleukin-6 blocking agents for treating COVID-19: a living systematic review.

Authors:  Lina Ghosn; Anna Chaimani; Theodoros Evrenoglou; Mauricia Davidson; Carolina Graña; Christine Schmucker; Claudia Bollig; Nicholas Henschke; Yanina Sguassero; Camilla Hansen Nejstgaard; Sonia Menon; Thu Van Nguyen; Gabriel Ferrand; Philipp Kapp; Carolina Riveros; Camila Ávila; Declan Devane; Joerg J Meerpohl; Gabriel Rada; Asbjørn Hróbjartsson; Giacomo Grasselli; David Tovey; Philippe Ravaud; Isabelle Boutron
Journal:  Cochrane Database Syst Rev       Date:  2021-03-18

Review 3.  Dealing with missing outcome data in meta-analysis.

Authors:  Dimitris Mavridis; Ian R White
Journal:  Res Synth Methods       Date:  2019-06-09       Impact factor: 5.273

4.  Pattern-mixture model in network meta-analysis of binary missing outcome data: one-stage or two-stage approach?

Authors:  Loukia M Spineli; Katerina Papadimitropoulou; Chrysostomos Kalyvas
Journal:  BMC Med Res Methodol       Date:  2021-01-07       Impact factor: 4.615

5.  Comparative efficacy and acceptability of different antihypertensive drug classes for cardiovascular disease prevention: protocol for a systematic review and network meta-analysis.

Authors:  Heidi Jussil; Anna Chaimani; Bo Carlberg; Mattias Brunström
Journal:  BMJ Open       Date:  2021-03-29       Impact factor: 2.692

6.  Allowing for uncertainty due to missing and LOCF imputed outcomes in meta-analysis.

Authors:  Dimitris Mavridis; Georgia Salanti; Toshi A Furukawa; Andrea Cipriani; Anna Chaimani; Ian R White
Journal:  Stat Med       Date:  2018-10-22       Impact factor: 2.373

Review 7.  Potential impact of missing outcome data on treatment effects in systematic reviews: imputation study.

Authors:  Lara A Kahale; Assem M Khamis; Batoul Diab; Yaping Chang; Luciane Cruz Lopes; Arnav Agarwal; Ling Li; Reem A Mustafa; Serge Koujanian; Reem Waziry; Jason W Busse; Abeer Dakik; Holger J Schünemann; Lotty Hooft; Rob Jpm Scholten; Gordon H Guyatt; Elie A Akl
Journal:  BMJ       Date:  2020-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.